ABVC BioPharma, Inc. Payments for (Proceeds from) Loans Receivable
ABVC BioPharma, Inc. (ABVC) reported Payments for (Proceeds from) Loans Receivable of $1.41 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromLoansReceivable · last filed 2026-03-03
- ABVC BioPharma, Inc. payments for (proceeds from) loans receivable for the quarter ending 2025-12-31 was $86.67K.
- ABVC BioPharma, Inc. payments for (proceeds from) loans receivable for the quarter ending 2025-09-30 was $511.11K.
- ABVC BioPharma, Inc. payments for (proceeds from) loans receivable for the quarter ending 2024-09-30 was -$44.83K.
- ABVC BioPharma, Inc. payments for (proceeds from) loans receivable for fiscal 2025 was $1.41M.
- ABVC BioPharma, Inc. payments for (proceeds from) loans receivable for fiscal 2020 was -$603.50K, a 3549.35% decline from fiscal 2019.
- ABVC BioPharma, Inc. payments for (proceeds from) loans receivable for fiscal 2019 was $17.50K.
| Period end | Payments for (Proceeds from) Loans Receivable 3 month | Payments for (Proceeds from) Loans Receivable 6 month | Payments for (Proceeds from) Loans Receivable 9 month | Payments for (Proceeds from) Loans Receivable 9 month as first filed | Payments for (Proceeds from) Loans Receivable 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $86.67K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $597.78K derived: sum of 2 quarters · filed 2026-03-03 | $1.41M 10-K · filed 2026-03-03 | ||
| 2025-09-30 | $511.11K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $1.32M 10-Q/A · filed 2026-03-03 | $2.08M 10-Q · filed 2025-11-03 | ||
| 2025-06-30 | $808.24K 10-Q · filed 2025-08-13 | ||||
| 2024-09-30 | -$44.83K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $456.79K 10-Q/A · filed 2026-03-03 | |||
| 2024-06-30 | $501.61K 10-Q · filed 2025-08-13 | ||||
| 2020-12-31 | -$603.50K 10-K · filed 2021-03-16 | ||||
| 2019-12-31 | $17.50K 10-K · filed 2021-03-16 |